Publications by authors named "M Di Eusanio"
Background: The introduction of transcatheter procedures has focused on patient expectations for treatments with a less invasive approach and faster recovery. The aim of this study was to assess the short- and medium-term results in patients who underwent trans-axillary mitral valve repair with application of the ultra-fast-track protocol.
Methods: Data from 431 patients undergoing isolated trans-axillary mitral valve repair or associated with tricuspid valve treatment between January 2018 and December 2023 were prospectively collected.
Objectives: Memo 4D is a semi-rigid ring with an exclusive saddle shape and progressive increased anteroposterior diameter. This preliminary analysis reports 30-day clinical and haemodynamic outcomes of the MANTRA Memo 4D sub-study.
Methods: MANTRA is an "umbrella" prospective, multicentre, worldwide post-market study to collect real-life safety and performance data on the Corcym devices.
Tricuspid regurgitation (TR) poses a significant healthcare burden and is a major concern for patients who experience debilitating symptoms and face a poorer prognosis. Cardiologists are showing renewed interest in TR, as the previous belief that it was merely a bystander of left-sided heart disease has evolved. As a result, more transcatheter techniques addressing TR are emerging.
View Article and Find Full Text PDFArticle Synopsis
- * The use of this approach significantly increased from 18.7% in 2019 to 97.8% by 2023, with a mean procedure time of 127 minutes and no intraoperative deaths reported.
- * Thirty-day adverse events included a 1.9% rate of major complications, with factors like intraoperative conversion and respiratory failure being linked to higher risks of complications and mortality.
Article Synopsis
- * Mitral valve repair was successful in 90.9% of cases, with posterior leaflet lesions showing the highest success rates, while the in-hospital mortality rate was low at 0.6%.
- * Results indicate that despite the emergence of less invasive techniques, surgical repair remains the best option for most DMR patients, with a 5-year survival rate of 95.5%.